Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations

Haematol Blood Transfus. 1990:33:489-93. doi: 10.1007/978-3-642-74643-7_88.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Dexamethasone / administration & dosage
  • Germany, West / epidemiology
  • Humans
  • Infant
  • Infant, Newborn
  • Leukocyte Count
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Multicenter Studies as Topic
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • Prednisone / administration & dosage
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk
  • Survival Rate
  • Teniposide / administration & dosage
  • Thioguanine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Vincristine
  • Dexamethasone
  • Cyclophosphamide
  • Teniposide
  • Mercaptopurine
  • Asparaginase
  • Thioguanine
  • Prednisone
  • Methotrexate
  • Daunorubicin